Results 211 to 220 of about 827,600 (338)
These findings elucidate the innovative role of HIC1 as a transcriptional activator in GC, driving the initiation of pyroptosis and enhancing CD8+ T cell infiltration, which has certain novelty and creative significance. Collectively, targeting HIC1 can present an appealing immunotherapeutic strategy to improve outcomes in GC patients.
Mengjie Kang+4 more
wiley +1 more source
Antibody-Drug Conjugate Stability Probed by Variable-Temperature Electrospray Ionization Mass Spectrometry. [PDF]
Fiala J, Schuster D, Heck AJR.
europepmc +1 more source
Utilizing a stereotaxic injection mouse model and a novel mathematical approach, this study uncovers key subnetworks that drive pathological α‐synuclein (α‐Syn) progression in Parkinson's disease (PD). Remarkably, just 2% of the strongest connections in the connectome are sufficient to predict its spread.
Yuanxi Li+16 more
wiley +1 more source
Insights into Active Site Cysteine Residues in <i>Mycobacterium tuberculosis</i> Enzymes: Potential Targets for Anti-Tuberculosis Intervention. [PDF]
Faponle AS, Gauld JW, de Visser SP.
europepmc +1 more source
The reducing power of cysteine [PDF]
David Frank Loewen, Edward C. Kendall
openaire +3 more sources
LincNEAT1 Encoded‐NEAT1‐31 micropeptide directly binds with Aurora‐A and enhanced AKT pathways to pormotes phagocytosis against multi cancer cells. Abstract Macrophages play vital roles in innate and adaptive immunity, and their essential functions are mediated by phagocytosis and antigen presentation.
Jie Li+8 more
wiley +1 more source
Intestinal permeability of N-acetylcysteine is driven by gut microbiota-dependent cysteine palmitoylation. [PDF]
Zhang YH+7 more
europepmc +1 more source
THE DETERMINATION OF THIOL AND DISULFIDE COMPOUNDS, WITH SPECIAL REFERENCE TO CYSTEINE AND CYSTINE
Kamenosuke Shinohara, Kively E. Padis
openalex +1 more source